Nanomedicine News

RSS

New Report on Global Nanobiotechnology Market

Research and Markets has announced the addition of Jain PharmaBiotech's new report "Nanobiotechnology Applications, Markets and Companies" to their offering.

From Research and Markets 12 Feb 2015

BIONOVA Offers Treatment for Blemish Control

Blemish skin is a common problem often confused with Acne. The cause of skin blemishes is the local imbalance of skin metabolism while Acne is a skin decease caused by hormonal imbalances, overactive sebum production (skin oil) and the existence of a specific bacterial flora. If Acne skin is always Oily, Blemish skin can be Normal, Oily and Dry type.

12 Feb 2015

Panacea, Accelovance Enter Agreement to Advance Novel Nanoparticle-Based Therapeutic Cancer Vaccine

Panacea Pharmaceuticals, Inc. and Accelovance Inc. today announced the establishment of a clinical development services agreement to develop and advance Panacea's oncology immunotherapy pipeline.

12 Feb 2015

Scottish Medicines Consortium Recommends ABRAXANE-Gemcitabine Combination for Metastatic Pancreatic Cancer Treatment

Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation, today announced that ABRAXANE®(paclitaxel formulated as albumin-bound nanoparticles; nab-paclitaxel), in combination with gemcitabine, has now received a positive recommendation for the treatment of metastatic pancreatic cancer by the Scottish Medicines Consortium (SMC) within the National Health Service Scotland.

12 Feb 2015

New Report on Global Transdermal Drug Delivery Market

ReportsnReports.com adds Global & USA Transdermal Drug Delivery Market to 2020: Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and SWOT Investigation research report to its store.

11 Feb 2015

Novel 3D Vaccine Offers More Effective Method to Harness the Immune System to Fight Cancer

NIBIB-funded researchers have developed a novel 3D vaccine that could provide a more effective way to harness the immune system to fight cancer as well as infectious diseases. The vaccine spontaneously assembles into a scaffold once injected under the skin and is capable of recruiting, housing, and manipulating immune cells to generate a powerful immune response. The vaccine was recently found to be effective in delaying tumor growth in mice.

11 Feb 2015

Vaxxas Secures A$25 Million Equity Funding to Advance Clinical Programs Using Nanopatch Vaccine Platform

Vaxxas, a biotechnology company commercializing a novel vaccination platform, today announced it has secured equity funding of A$25 million [US$20 million] from new and existing investors.

10 Feb 2015

PEG-HCC Nanoparticle Can Catalyze Neutralization of Damaging Reactive Oxygen Species Molecules

Injectable nanoparticles that could protect an injured person from further damage due to oxidative stress have proven to be astoundingly effective in tests to study their mechanism.

10 Feb 2015

Biology Major Co-Authors Nature Nanotechnology Paper on siRNA Delivery Research

Since day one at MIT, senior Yiping Xing has been interested in exploring medicine from different perspectives. Already, the biology major has co-authored two scientific papers, including a Nature Nanotechnology paper on siRNA delivery research; co-led a project in Ghana to convert organic waste into animal feed; and participated in national health policy through an internship in the U.S. Surgeon General’s office.

9 Feb 2015

Small, Low Cost Microfluidic Device to Rapidly Detect Allergies or Diseases

Gabriel Caballero Robledo from the Center for Research and Advanced Studies (CINVESTAV)at Monterrey, Mexico, is working on the design of a small medical device capable of detecting allergies or diseases quickly and at a low cost.

9 Feb 2015